Hye Ri Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hye Ri Kim has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Dong Hoon Shin
Department of Dermatology, Yeungnam University College of Medicine, Daegu, Korea
6 shared publications - Jong Soo Choi
Department of Dermatology, College of Medicine, Yeungnam University, Daegu, Korea
6 shared publications - Hyeong Mok Kwon
Department of Dermatology, Yeungnam University College of Medicine, Daegu, Korea
4 shared publications - Young Kyung Bae
Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea
4 shared publications - Jung Eun Yim
Department of Dermatology, Yeungnam University College of Medicine, Daegu, Korea
3 shared publications - Joon Hyuk Choi
Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea
2 shared publications
Latest Publications
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 2) , S272-S274
Methotrexate-Induced Accelerated Nodulosis in a Patient with Systemic Lupus Erythematosus
Methotrexate (MTX)-induced accelerated nodulosis (MIAN) reportedly occurs in patients with rheumatic arthritis receiving MTX therapy. However, it has also been reported in patients with other autoinflammatory conditions, such as systemic lupus erythematosus (SLE). A 38-year-old woman diagnosed with SLE presented with multiple movable, firm, fleshcolored nodules on both hands that had developed 3 years ago. She was taking oral medications, specifically hydroxychloroquine, azathioprine, and MTX. Histopathological examination revealed palisaded granulomatous inflammation, surrounded by histiocytes and lymphocytes, along the dermis to the subcutaneous fat layer. Fibrinoid degeneration was observed at the center of the granulomatous inflammation, and dermal mucin deposition was not observed. The patient was diagnosed with MIAN, and therefore discontinuation of MTX was recommended. Subsequently, the lesions almost completely disappeared with no signs of recurrence. MIAN exhibits clinicopathological features similar to those of rheumatoid nodules; therefore, it can be easily misdiagnosed. Herein, we report a case of MIAN in a patient with SLE to contribute to the accurate diagnosis and appropriate management.
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 2) , S272-S274
Open AccessMethotrexate-Induced Accelerated Nodulosis in a Patient with Systemic Lupus Erythematosus
Methotrexate (MTX)-induced accelerated nodulosis (MIAN) reportedly occurs in patients with rheumatic arthritis receiving MTX therapy. However, it has also been reported in patients with other autoinflammatory conditions, such as systemic lupus erythematosus (SLE). A 38-year-old woman diagnosed with SLE presented with multiple movable, firm, fleshcolored nodules on both hands that had developed 3 years ago. She was taking oral medications, specifically hydroxychloroquine, azathioprine, and MTX. Histopathological examination revealed palisaded granulomatous inflammation, surrounded by histiocytes and lymphocytes, along the dermis to the subcutaneous fat layer. Fibrinoid degeneration was observed at the center of the granulomatous inflammation, and dermal mucin deposition was not observed. The patient was diagnosed with MIAN, and therefore discontinuation of MTX was recommended. Subsequently, the lesions almost completely disappeared with no signs of recurrence. MIAN exhibits clinicopathological features similar to those of rheumatoid nodules; therefore, it can be easily misdiagnosed. Herein, we report a case of MIAN in a patient with SLE to contribute to the accurate diagnosis and appropriate management.
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S25-S29
Superficial CD34-Positive Fibroblastic Tumor: Two Case Reports
Yim JE, et al. Ann Dermatol. 2023 May;35:e36. https://doi.org/10.5021/ad.20.328
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S25-S29
Open AccessSuperficial CD34-Positive Fibroblastic Tumor: Two Case Reports
Yim JE, et al. Ann Dermatol. 2023 May;35:e36. https://doi.org/10.5021/ad.20.328
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S10-S13
Intradermal Low-Fat Spindle Cell Lipoma: A Case Report
Kwon HM, et al. Ann Dermatol. 2023 May;35:e33. https://doi.org/10.5021/ad.21.051
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S10-S13
Open AccessIntradermal Low-Fat Spindle Cell Lipoma: A Case Report
Kwon HM, et al. Ann Dermatol. 2023 May;35:e33. https://doi.org/10.5021/ad.21.051
- Open Access
- 31 March 2020
- Published by Korean Society for Medical Mycology in Korean Journal of Medical Mycology
- p. 22-25
Tinea Pseudoimbricata caused by Trichophyton rubrum
Tinea pseudoimbricata, a special subset of tinea incognito, is a cutaneous fungal infection with unusual tinea imbricata-like lesions caused by dermatophytes other than Trichophyton concentricum. Here we present a case of tinea pseudoimbricata. An 80-year-old woman presented with mildly pruritic, scaly, annular, erythematous plaques with inner small, annular, polycyclic, or arcuate plaques on the left abdomen and back for 1 month. The lesions enlarged after the application of topical corticosteroids about 2 months previously. A potassium hydroxide test performed on her lesions was positive. Fungal culture, light microscopic findings, and T. rubrum-specific real-time polymerase chain reaction confirmed the presence of T. rubrum. Thus, we diagnosed tinea pseudoimbricata caused by T. rubrum and treated successfully with oral and topical terbinafine.
- 31 March 2020
- Published by Korean Society for Medical Mycology in Korean Journal of Medical Mycology
- p. 22-25
Open AccessTinea Pseudoimbricata caused by Trichophyton rubrum
Tinea pseudoimbricata, a special subset of tinea incognito, is a cutaneous fungal infection with unusual tinea imbricata-like lesions caused by dermatophytes other than Trichophyton concentricum. Here we present a case of tinea pseudoimbricata. An 80-year-old woman presented with mildly pruritic, scaly, annular, erythematous plaques with inner small, annular, polycyclic, or arcuate plaques on the left abdomen and back for 1 month. The lesions enlarged after the application of topical corticosteroids about 2 months previously. A potassium hydroxide test performed on her lesions was positive. Fungal culture, light microscopic findings, and T. rubrum-specific real-time polymerase chain reaction confirmed the presence of T. rubrum. Thus, we diagnosed tinea pseudoimbricata caused by T. rubrum and treated successfully with oral and topical terbinafine.
- Open Access
- 1 January 2020
- Published by XMLink in Annals of Dermatology
- Vol. 32 (1) , 53-56
Necrobiotic Xanthogranuloma Coexists with Diffuse Normolipidemic Plane Xanthoma and Multiple Myeloma
Necrobiotic xanthogranuloma (NXG), is a rare multisystem disease that manifests as cutaneous inflammatory lesions, and is commonly associated with lymphoproliferative disease. Diffuse normolipemic plane xanthoma (NX), is also a rare, acquired disease that is often associated with systemic diseases such as lymphoproliferative disease. Both of these diseases have been reported to be associated with monoclonal gammopathy (MG). However, there are few cases in which these diseases co-exist. A 78-year-old female, who had a known case of NX on the neck and axillary area, presented with an asymptomatic erythematous plaque on her left supraclavicular area. Histopathological examination showed lymphoid aggregates, necrobiotic areas, and granulomatous inflammation in the dermis. Numerous foreignbody and Touton type giant cells were noticed. Serum protein immunoelectrophoresis showed an IgG kappa type MG. Lipid profile of the patient was normal. Bone marrow examination showed plasma cell myeloma. Based on these histologic and laboratory results, we diagnosed this lesion as NXG coexisting with NX and multiple myeloma. She was started on treatment with bortezomib and melphalan for multiple myeloma, and high-dose systemic corticosteroid and triamcinolone intralesional injection for the skin lesion. After 3 months of treatment, the NXG skin lesion and MG improved.
- 1 January 2020
- Published by XMLink in Annals of Dermatology
- Vol. 32 (1) , 53-56
Open AccessNecrobiotic Xanthogranuloma Coexists with Diffuse Normolipidemic Plane Xanthoma and Multiple Myeloma
Necrobiotic xanthogranuloma (NXG), is a rare multisystem disease that manifests as cutaneous inflammatory lesions, and is commonly associated with lymphoproliferative disease. Diffuse normolipemic plane xanthoma (NX), is also a rare, acquired disease that is often associated with systemic diseases such as lymphoproliferative disease. Both of these diseases have been reported to be associated with monoclonal gammopathy (MG). However, there are few cases in which these diseases co-exist. A 78-year-old female, who had a known case of NX on the neck and axillary area, presented with an asymptomatic erythematous plaque on her left supraclavicular area. Histopathological examination showed lymphoid aggregates, necrobiotic areas, and granulomatous inflammation in the dermis. Numerous foreignbody and Touton type giant cells were noticed. Serum protein immunoelectrophoresis showed an IgG kappa type MG. Lipid profile of the patient was normal. Bone marrow examination showed plasma cell myeloma. Based on these histologic and laboratory results, we diagnosed this lesion as NXG coexisting with NX and multiple myeloma. She was started on treatment with bortezomib and melphalan for multiple myeloma, and high-dose systemic corticosteroid and triamcinolone intralesional injection for the skin lesion. After 3 months of treatment, the NXG skin lesion and MG improved.
- Open Access
- 30 June 2019
- Published by Korean Society for Medical Mycology in Korean Journal of Medical Mycology
- p. 45-51
Molecular Identification of Human Sporotrichosis in Korea
Background: Sporotrichosis is a common deep mycosis caused by the Sporothrix schenckii complex. Until 2016, no molecular studies had been conducted on these fungi, and all the included strains were reported as S. schenckii. However, investigations conducted in northeast China, Japan, and India revealed that S. globosa was the most prevalent Sporothrix species, whereas S. schenckii sensu stricto was reported very rarely. Objective: To investigate the accurate prevalent causative species of sporotrichosis among strains reported as S.schenckii in Korea. Methods: We isolated strains of Sporothrix spp. Prevalent in Korea from fungus collection centers or private collections and reviewed the available literature on molecular studies of strains from this region. We found five S. schenckii (1998-2016) and three S. globosa (2016-2018) strains. Ribosomal DNA internal transcribed spacer (ITS) sequences of these strains were compared with those of the S. schenckii complex strains. Results: The ribosomal ITS sequences of the eight strains were 100% identical with that of S. globose. No S. schenckii sensu stricto was found. In addition, a study on the molecular analysis of Korean S. schenckii published by Ishizaki et al. (2004) demonstrated that the eight strains were of the mitochondrial subtype group B (S. globosa). Thus, all the 16 strains examined within the Korean S. schenckii complex were determined to be S. globosa. Conclusion: In summary, S. globosa is the causative species within the tested Korean sporotrichosis cases reported between 1998 and 2018. Based on our analyses, S. globosa, and not S. schenckii, may be the predominant species in Korea.
- 30 June 2019
- Published by Korean Society for Medical Mycology in Korean Journal of Medical Mycology
- p. 45-51
Open AccessMolecular Identification of Human Sporotrichosis in Korea
Background: Sporotrichosis is a common deep mycosis caused by the Sporothrix schenckii complex. Until 2016, no molecular studies had been conducted on these fungi, and all the included strains were reported as S. schenckii. However, investigations conducted in northeast China, Japan, and India revealed that S. globosa was the most prevalent Sporothrix species, whereas S. schenckii sensu stricto was reported very rarely. Objective: To investigate the accurate prevalent causative species of sporotrichosis among strains reported as S.schenckii in Korea. Methods: We isolated strains of Sporothrix spp. Prevalent in Korea from fungus collection centers or private collections and reviewed the available literature on molecular studies of strains from this region. We found five S. schenckii (1998-2016) and three S. globosa (2016-2018) strains. Ribosomal DNA internal transcribed spacer (ITS) sequences of these strains were compared with those of the S. schenckii complex strains. Results: The ribosomal ITS sequences of the eight strains were 100% identical with that of S. globose. No S. schenckii sensu stricto was found. In addition, a study on the molecular analysis of Korean S. schenckii published by Ishizaki et al. (2004) demonstrated that the eight strains were of the mitochondrial subtype group B (S. globosa). Thus, all the 16 strains examined within the Korean S. schenckii complex were determined to be S. globosa. Conclusion: In summary, S. globosa is the causative species within the tested Korean sporotrichosis cases reported between 1998 and 2018. Based on our analyses, S. globosa, and not S. schenckii, may be the predominant species in Korea.